Obesity, Cardiovascular Disease and Sleep Disorders: Insights into the Rising EpidemicNavneet Sharma, Justin Lee, Irini Youssef, Moro O Salifu and Samy I McFarlane*
Department of Medicine, Divisions of Endocrinology and Nephrology, New York, USA
- *Corresponding Author:
- Samy I McFarlane
Department of Medicine, Divisions of Endocrinology, State University of New York
Downstate Medical Center, Brooklyn District President, American College of Physicians
450 Clarkson Avenue, Brooklyn, New York, 11203, USA
E-mail: [email protected]
Received date: February 28, 2017; Accepted date: March 1, 2017; Published date: March 10, 2017
Citation: Sharma N, Lee J, Youssef I, Salifu MO, McFarlane SI (2017) Obesity, Cardiovascular Disease and Sleep Disorders: Insights into the Rising Epidemic. J Sleep Disord Ther 6:260. doi:10.4172/2167-0277.1000260
Copyright: © 2017 Sharma N, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Cardiovascular disease (CVD) is the main cause of death among adult men and women in the USA and impacts millions around the globe. Traditional risk factors for CVD include obesity, diabetes, hypertension and dyslipidemia. The modern-day epidemic of obesity not only increased the rate of CVD but also ushered in an additional CVD risk factor to be added to the list; that is obstructive sleep apnea (OSA). In this review, we discuss the growing epidemic of obesity and OSA, highlighting the resembling pathogenic hypotheses linking these risk factors to CVD. We will also highlight the therapeutic rationale of OSA as a way to reduce CVD risk.